Alessio Mosca

708 total citations
38 papers, 399 citations indexed

About

Alessio Mosca is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, Alessio Mosca has authored 38 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 12 papers in Pharmacology and 10 papers in Clinical Psychology. Recurrent topics in Alessio Mosca's work include Schizophrenia research and treatment (8 papers), Treatment of Major Depression (7 papers) and Bipolar Disorder and Treatment (6 papers). Alessio Mosca is often cited by papers focused on Schizophrenia research and treatment (8 papers), Treatment of Major Depression (7 papers) and Bipolar Disorder and Treatment (6 papers). Alessio Mosca collaborates with scholars based in Italy, United Kingdom and United States. Alessio Mosca's co-authors include Giovanni Martinotti, Mauro Pettorruso, Stefania Chiappini, Andrea Miuli, Maria Chiara Santovito, Massimo di Giannantonio, Francesco Di Carlo, Fabrizio Schifano, Amira Guirguis and John Corkery and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neuroscience & Biobehavioral Reviews and International Journal of Environmental Research and Public Health.

In The Last Decade

Alessio Mosca

29 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessio Mosca Italy 12 145 123 119 74 51 38 399
Gia Han Le Canada 10 83 0.6× 90 0.7× 121 1.0× 60 0.8× 18 0.4× 76 419
Flavia Napoletano Italy 12 192 1.3× 208 1.7× 135 1.1× 94 1.3× 122 2.4× 20 491
Andrea Miuli Italy 14 226 1.6× 155 1.3× 120 1.0× 108 1.5× 61 1.2× 46 643
Thomas M. Penders United States 12 186 1.3× 85 0.7× 90 0.8× 76 1.0× 146 2.9× 24 569
M. Maffini Italy 6 70 0.5× 193 1.6× 69 0.6× 78 1.1× 24 0.5× 7 392
Silvia Paletta Italy 12 112 0.8× 382 3.1× 128 1.1× 96 1.3× 25 0.5× 29 673
Jon Mordal Norway 10 102 0.7× 140 1.1× 39 0.3× 51 0.7× 72 1.4× 22 352
Chiara Montemitro Italy 15 235 1.6× 118 1.0× 62 0.5× 115 1.6× 40 0.8× 33 545
Muhammad Youshay Jawad Canada 14 126 0.9× 123 1.0× 227 1.9× 89 1.2× 17 0.3× 31 551
R. Vecchiotti Italy 7 129 0.9× 118 1.0× 58 0.5× 48 0.6× 9 0.2× 13 349

Countries citing papers authored by Alessio Mosca

Since Specialization
Citations

This map shows the geographic impact of Alessio Mosca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessio Mosca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessio Mosca more than expected).

Fields of papers citing papers by Alessio Mosca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessio Mosca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessio Mosca. The network helps show where Alessio Mosca may publish in the future.

Co-authorship network of co-authors of Alessio Mosca

This figure shows the co-authorship network connecting the top 25 collaborators of Alessio Mosca. A scholar is included among the top collaborators of Alessio Mosca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessio Mosca. Alessio Mosca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
d’Andrea, Giacomo, R Tucci, Alessio Mosca, et al.. (2025). Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Translational Psychiatry. 15(1). 453–453.
2.
Mosca, Alessio, Stefania Chiappini, Andrea Miuli, et al.. (2025). Eco-Anxiety and Mental Health: Correlates of Climate Change Distress. International Journal of Environmental Research and Public Health. 22(12). 1768–1768.
3.
Chiappini, Stefania, Alessio Mosca, Denis Pelletier, et al.. (2025). Adverse Drug Reactions Associated with Concomitant Use of Calcium Channel Blockers and Cocaine: An Analysis of FDA Adverse Events Reporting System Data. Journal of Clinical Medicine. 14(10). 3461–3461.
4.
5.
Lupi, Matteo, Stefania Chiappini, Alessio Mosca, et al.. (2025). Alcohol Use Disorders and Suicidal Behaviour: A Narrative Review. Actas Españolas de Psiquiatría. 53(1). 165–180.
6.
Chiappini, Stefania, Alessio Mosca, Francesco Semeraro, et al.. (2025). Navigating the challenges of substance use and psychopathology in depression, bipolar disorder, and schizophrenia. Comprehensive Psychiatry. 142. 152616–152616.
7.
d’Andrea, Giacomo, Alessio Mosca, Francesco Di Carlo, et al.. (2025). PHARMACOVIGILANCE SIGNALS OF SEMAGLUTIDE AND OTHER GLP-1 RECEPTOR AGONISTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION (FDA) ADVERSE EVENTS REPORTING SYSTEM (FAERS) DATASET. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i300–i300.
8.
Montemitro, Chiara, Alessio Mosca, Stefania Chiappini, et al.. (2024). Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain. Pharmaceuticals. 17(10). 1387–1387. 1 indexed citations
9.
Chiappini, Stefania, Alessio Mosca, Francesco Di Carlo, et al.. (2024). Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study. Pharmaceuticals. 17(4). 535–535. 12 indexed citations
10.
Mosca, Alessio, Stefania Chiappini, Andrea Miuli, et al.. (2024). Piperazine Abuse and Psychosis: A Systematic Review of the Literature. SHILAP Revista de lepidopterología. 5(3). 552–563. 1 indexed citations
11.
Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2024). New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. Neuroscience & Biobehavioral Reviews. 162. 105691–105691. 19 indexed citations
12.
Chiappini, Stefania, Alessio Mosca, Giacomo d’Andrea, et al.. (2024). Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation. Journal of Clinical Medicine. 13(8). 2206–2206. 6 indexed citations
13.
Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2024). Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. Frontiers in Psychiatry. 15. 1508732–1508732. 4 indexed citations
14.
Chiappini, Stefania, Amira Guirguis, Nicolò Schifano, et al.. (2024). Comparative safety of prescribed Esketamine and ketamine in relation to renal and urinary disorders: A pharmacovigilance perspective. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 136. 111213–111213. 6 indexed citations
15.
Miuli, Andrea, et al.. (2023). Could Cariprazine Be a Possible Choice for High Functioning Autism? A Case Report. SHILAP Revista de lepidopterología. 3(4). 908–915.
16.
Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2022). Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines. 10(2). 355–355. 16 indexed citations
17.
Mosca, Alessio, Stefania Chiappini, Andrea Miuli, et al.. (2022). Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: ASystematic Review of the Current Literature. Current Neuropharmacology. 21(11). 2178–2194. 13 indexed citations
18.
Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2021). New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina. 57(6). 580–580. 36 indexed citations
19.
Martinotti, Giovanni, Stefania Chiappini, Mauro Pettorruso, et al.. (2021). Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain Sciences. 11(7). 856–856. 59 indexed citations
20.
Schifano, Fabrizio, Stefania Chiappini, Andrea Miuli, et al.. (2021). Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Frontiers in Psychiatry. 12. 657397–657397. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gia Han Le Breakdown of academic impact, for papers by Flavia Napoletano Breakdown of academic impact, for papers by Andrea Miuli Breakdown of academic impact, for papers by Thomas M. Penders Breakdown of academic impact, for papers by M. Maffini Breakdown of academic impact, for papers by Silvia Paletta Breakdown of academic impact, for papers by Jon Mordal Breakdown of academic impact, for papers by Chiara Montemitro Breakdown of academic impact, for papers by Muhammad Youshay Jawad Breakdown of academic impact, for papers by R. Vecchiotti
Rankless by CCL
2026